A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The proposed study will establish the safety and efficacy of modafinil in the treatment of
methamphetamine dependence, as well as assess the affects of modafinil on cognitive function
in methamphetamine users and on methamphetamine withdrawal symptoms. In this outpatient
trial, methamphetamine- dependent, treatment-seeking subjects will receive modafinil or
placebo daily for four weeks, along with weekly Motivational Enhancement Therapy sessions.
This study will be conducted at the Addiction & Pharmacology Laboratory in San Francisco, CA,
and at the New Leaf Treatment Center in Lafayette, CA, and is expected to last one year.
Phase:
Phase 2
Details
Lead Sponsor:
California Pacific Medical Center Research Institute